Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2016
Flow Cytometric Analysis of Extracellular VesiclesAizea Morales-Kastresana, Jennifer C Jones
Current Protocols in Cytometry|December 17, 2020
Detection and Sorting of Extracellular Vesicles and Viruses Using nanoFACSAizea Morales-Kastresana, Joshua A Welsh, Jennifer C Jones
Oncoimmunology|July 26, 2014
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancerAizea Morales-Kastresana, Sara Labiano, Ines Gütgemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Better performance of CARs deprived of the PD-1 brakeAizea Morales-Kastresana, Sara Labiano, José I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
Agonist antibodies to TNFR molecules that costimulate T and NK cellsIgnacio Melero, Daniel Hirschhorn-Cymerman, Aizea Morales-Kastresana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2011
Molecular pathways: hypoxia response in immune cells fighting or promoting cancerAsis Palazón, Julián Aragonés, Aizea Morales-Kastresana, et al.
International Review of Cell and Molecular Biology|July 1, 2022
Anticalin®-based therapeutics: Expanding new frontiers in drug developmentAizea Morales-Kastresana, Martin Siegemund, Stefan Haak, et al.
Journal of Extracellular Vesicles|March 15, 2018
Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexesDionysios C Watson, Bryant C Yung, Cristina Bergamaschi, et al.
Oncoimmunology|October 25, 2019
Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memoryAnja C Bloom, Lewis H Bender, Shweta Tiwary, et al.
Journal for Immunotherapy of Cancer|April 26, 2014
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAbAizea Morales-Kastresana, Elena Catalán, Sandra Hervás-Stubbs, et al.
Pageof 9